We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04398524
Brief Title: A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

First Submitted : May 18, 2020
First Submitted that Met QC Criteria : May 18, 2020
First Posted : May 21, 2020

Last Update Submitted that Met QC Criteria : October 11, 2022
Last Update Posted : October 13, 2022